Universal Health Services falls 4.5% because of third-quarter earnings surprise

What happened

Universal Health Services (UHS) fell 4.5% on October 27, 2026, after third-quarter results released that day. The stock closed at $177.32 after having opened 0.9% above the previous close. Trading volume ran at 2.3 times its 20-day average as investors digested the report; the S&P 500 rose 0.6% and the healthcare sector median rose 1.6% on the same day.

How big was the move

The decline was 2.8 times a typical daily move for this stock and was 6.1 percentage points worse than the sector median for the day. Market value stood at $11.01 billion. With a beta of 0.43, the stock tends to move less than the market, so a fall of this size represented a relatively large one-day re-pricing for the company. In the past five years the stock had 20 sessions with a decline of at least 4.5%; twenty trading days later the median result was a gain of 2.3%, and 11 of 20 were higher.

The technical picture

Technically, the stock sat 1.8% below its 20-day moving average and 0.1% above its 50-day moving average, while it was 0.0% below its 200-day moving average. The 50-day average is below the 200-day average, a sign of a weak longer-term trend. The Relative Strength Index (14 days) was 46, inside a neutral range between 30 and 70. The shares were 28.0% below the 52-week high. Over one month the stock fell 0.1%, over three months it rose 5.4% and over one year it fell 15.8%, which left it 29.5 percentage points behind the S&P 500. Volatility was 26% annualized over 60 days, lower than 70% of its own readings over five years, suggesting recent price swings were modest by historical standards.

Fundamentals and valuation

For the four quarters through September 30, 2026, revenue was $18.35 billion, which grew 8.0% from a year earlier. Gross margin stood at 67.3% compared with a year earlier figure of 90.3%, and operating margin was 10.8% versus 11.5% a year earlier. Return on invested capital was 11.7%. The balance sheet shows net debt of 2.2 times EBITDA. On one common valuation measure, the stock traded at 7.9 times expected earnings on a price to forward earnings basis.

Those figures present a mixed picture for investors. Revenue growth remained positive, but gross margin and operating margin each contracted year over year. Leverage, at net debt of 2.2 times EBITDA, will be watched as reimbursement and interest-rate pressures evolve. The valuation measure of 7.9 times expected earnings suggests the market is assigning a relatively low multiple to the company’s near-term earnings, even as PromtFinance scores rank Value and Quality highly.

Earnings and analyst expectations

Universal Health Services reported diluted earnings per share of $5.22 for the quarter in its October 27, 2026, report, versus $5.19 expected, 0.6% above estimates. The result extended a streak of three consecutive quarters beating estimates; the average surprise over the last four reports was 1.1% above estimates. Zacks Investment Research noted the third-quarter results showing diluted earnings of $5.22 per share and said the result was below the Zacks Consensus Estimate of $5.31 and down from $5.69 a year earlier.

Typical two-day reactions after recent reports have been a fall of 0.2%. The stock’s larger fall on October 27, 2026, suggests investors focused not just on the slight earnings beat but on the mix of margin compression, growth coming off a higher one-quarter growth of 10.0% a year earlier, and balance-sheet leverage. The next report is due March 3, 2027.

What to watch

• March 3, 2027: next scheduled earnings report.
• Consensus price target $193.00, which is 8.8% above the closing price.
• Number of analysts with a rating: 44; share rating Buy or Strong Buy: 39%; consensus rating: Hold.
• Balance-sheet leverage: net debt of 2.2 times EBITDA.